Surfactant therapies for pediatric and neonatal ARDS: ESPNIC expert consensus opinion for future research steps

Pediatric (PARDS) and neonatal (NARDS) acute respiratory distress syndrome have different age-specific characteristics and definitions. Trials on surfactant for ARDS in children and neonates have been performed well before the PARDS and NARDS definitions and yielded conflicting results. This is main...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Critical care (London, England) England), 2021-02, Vol.25 (1), p.75-75, Article 75
Hauptverfasser:	De Luca, Daniele, Cogo, Paola, Kneyber, Martin C, Biban, Paolo, Semple, Malcolm Grace, Perez-Gil, Jesus, Conti, Giorgio, Tissieres, Pierre, Rimensberger, Peter C
Format:	Artikel
Sprache:	eng
Schlagworte:	Age Biological products Care and treatment Child Child, Preschool Children Complications and side effects Critical care Expert Testimony Forecasting - methods Health aspects Humans Infant Infant, Newborn Inflammation Life Sciences Literature reviews Mortality NARDS Neonate Newborn babies PARDS Patient outcomes Pediatric respiratory diseases Pediatrics Pediatrics - instrumentation Pediatrics - trends Peptides Proteins Research - trends Respiratory distress syndrome Respiratory Distress Syndrome - mortality Respiratory Distress Syndrome - physiopathology Respiratory Distress Syndrome - therapy Review Surface active agents Surface-Active Agents - therapeutic use Surfactant Surfactants
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!